Clínica Médica
Biomarcadores podem ser um sinal de alerta precoce para a presença de arterite de células gigantes em pacientes com polimialgia reumática.
25 Mar, 2022 | 14:33hComentário: Biomarkers may improve giant cell arteritis diagnosis – medwireNews
Comentário no Twitter
In our newest paper we investigated biomarkers that aid the diagnosis of Giant Cell Arteritis versus PMR or other mimicing conditions. This time, we worked together with our colleagues in Aarhus, Denmark to measure the biomarkers in 2 independent cohortshttps://t.co/d6PWsGSl2H
— Yannick van Sleen (@SleenYannick) March 11, 2022
Revisão para clínicos gerais | Abordagem clínica da perda visual.
25 Mar, 2022 | 14:26hClinical approach to vision loss: a review for general physicians – Clinical Medicine Journal
Retinopatia diabética para o não oftalmologista.
25 Mar, 2022 | 14:25hDiabetic retinopathy for the non-ophthalmologist – Clinical Medicine Journal
Doença inflamatória ocular: visão geral da apresentação clínica e tratamento.
25 Mar, 2022 | 14:24hDiplopia: diagnóstico e tratamento.
25 Mar, 2022 | 14:23hDiplopia: Diagnosis and management – Clinical Medicine Journal
Atualização da abordagem clínica da arterite de células gigantes.
25 Mar, 2022 | 14:21hAn update on the clinical approach to giant cell arteritis – Clinical Medicine Journal
OMS lança diretrizes de tratamento clínico para influenza.
24 Mar, 2022 | 12:36hComunicado de imprensa: WHO releases clinical management guidelines for influenza – World Health Organization
Relatório original: Guidelines for the clinical management of severe illness from influenza virus infections – World Health Organization
Colaboração e compartilhamento na tomada de decisão entre médicos e pacientes nas decisões de cuidados preventivos de saúde e recomendações da US Preventive Services Task Force.
24 Mar, 2022 | 12:34hEstudo randomizado | Entre pacientes críticos com Covid-19, o tratamento com um agente antiplaquetário teve pouca propensão a melhorar os dias sem suporte de órgão em 21 dias.
24 Mar, 2022 | 12:33hEditorial: Thromboinflammation and Antithrombotics in COVID-19: Accumulating Evidence and Current Status – JAMA
Comentário: Aspirin may improve 3-month survival for patients critically ill with COVID-19 – Imperial College London
Comentários no Twitter
In this bayesian randomized clinical trial, among critically ill patients with #COVID19, there was a low likelihood that treatment with an antiplatelet agent provided improvement in organ support–free days within 21 days. https://t.co/CnyWoOTn3Q
— JAMA (@JAMA_current) March 22, 2022